These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 549299)

  • 21. The role of phosphate and other factors on the pathogenesis of renal osteodystrophy.
    Slatopolsky E; Rutherford WE; Martin K; Hruska K
    Adv Exp Med Biol; 1977; 81():467-75. PubMed ID: 899937
    [No Abstract]   [Full Text] [Related]  

  • 22. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 23. Parathyroid hormone and biochemical profile in chronic kidney disease patients in South India.
    Sankarasubbaiyan S; Abraham G; Soundararajan P; Chandrasekaran V; Padma G
    Hemodial Int; 2005 Jan; 9(1):63-7. PubMed ID: 16191055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure.
    Tessitore N; Venturi A; Adami S; Roncari C; Rugiu C; Corgnati A; Bonucci E; Maschio G
    Miner Electrolyte Metab; 1987; 13(1):38-44. PubMed ID: 3587183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-alpha-hydroxycholecalciferol treatment of adults with chronic renal failure.
    Madsen S; Olgaard K
    Acta Med Scand; 1976; 200(1-2):1-5. PubMed ID: 961464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
    Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
    Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in the therapy of secondary hyperparathyroidism.
    Wood C; González EA; Martin KJ
    Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium and phosphorus in diet therapy of uremia.
    Schoolwerth AC; Engle JE
    J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vitamin D metabolism and chronic kidney insufficiency].
    Schaefer K; von Herrath D; Kraft D
    Dtsch Med Wochenschr; 1973 Jul; 98(27):1338-44. PubMed ID: 4351844
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vitamin A status of patients with chronic renal failure in relation to renal osteodystrophy].
    Stein G; Abendroth K; Kokot F; Keil E; Schöne S; Wessel G; Fünfstück R; Sperschneider H
    Z Urol Nephrol; 1985 Mar; 78(3):159-65. PubMed ID: 4002896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients.
    Messa P; Vallone C; Mioni G; Geatti O; Turrin D; Passoni N; Cruciatti A
    Kidney Int; 1994 Dec; 46(6):1713-20. PubMed ID: 7700031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of age and sex on blood levels of calcium-regulating hormones in dogs.
    Meller Y; Kestenbaum RS; Yagil R; Shany S
    Clin Orthop Relat Res; 1984; (187):296-9. PubMed ID: 6744733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alphacalcidol oral pulses are effective in secondary hyperparathyroidism prior to dialysis.
    Koskimies O; Ala-Houhala M
    Clin Nephrol; 1996 Jul; 46(1):70-1. PubMed ID: 8832157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of bone mineral content and correlations with calciotropic hormones in periodic hemodialysis patients].
    Anelli F; De Maio P; Girardi V; Papagni S; Rossi G; Cantatore FP; Carrozzo M
    Minerva Urol Nefrol; 1992; 44(4):265-73. PubMed ID: 1299008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mineral homeostasis during lactation- relationship to serum 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, parathyroid hormone and calcitonin.
    Greer FR; Tsang RC; Searcy JE; Levin RS; Steichen JJ
    Am J Clin Nutr; 1982 Sep; 36(3):431-7. PubMed ID: 6896793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the pathogenesis and pathophysiology of renal osteodystrophy. II. Bone histology of chronic renal failure patients at the time of starting hemodialysis].
    Sato T
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1145-58. PubMed ID: 7815747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis.
    Baradaran A; Nasri H
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):344-50. PubMed ID: 16970254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone histomorphometry of renal osteodystrophy in diabetic patients.
    Andress DL; Hercz G; Kopp JB; Endres DB; Norris KC; Coburn JW; Sherrard DJ
    J Bone Miner Res; 1987 Dec; 2(6):525-31. PubMed ID: 3455634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoreactive serum calcitonin and skeletal histology in chronic renal failure.
    Furlong T; Chan YL; Cornish C; McDowall D; Mahony J; Clifton-Bligh P
    Nephron; 1991; 58(2):138-43. PubMed ID: 1865968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.